Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

13

Revenue 2014

Teva

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Teva's 2013 sales performance.

Teva sheds R&D chief after new CEO takes the helm

Teva sheds R&D chief after new CEO takes the helm

Teva employs around 7, 000 people in Israel, with thousands more working in companies serving the pharma company. ... at Lundbeck - and shares in Teva closed up 5.3% in the wake of the announcement.

Teva launches personalised digital support for MS patients

Teva launches personalised digital support for MS patients Teva launches personalised digital support for MS patients. Says its MS Care Programme is the first of its kind. ... Teva has launched a new patient support programme that offers personalised, flexible digital support to patients with relapsing forms of

The Value of Targeted Therapies - a Case Study in Defining, Documenting and Delivering Value in Severe Eosinophilic Asthma (SEA)

Teva demonstrated that this is an optimal patient population for reslizumab and that there is unmet need for broader access. ... The involvement from patient associations was a splendid touch. This submission really resonated with us and Teva should be

AZ prices severe asthma drug Fasenra below competition

AZ prices severe asthma drug Fasenra below competition The US FDA has approved AstraZeneca’s interleukin-5 inhibitor Fasenra for severe asthma, setting up a fight in the market with rival drugs from GlaxoSmithKline and Teva. ... battle to its competitors by pricing the drug at a discount to GSK’s Nucala

AZ severe asthma drug benralizumab backed by CHMP

AZ is vying to make the drug the third IL-5 inhibitor to reach the market for severe asthma after GlaxoSmithKline’s Nucala (mepolizumab) and Teva's Cinqaero (reslizumab), and says ... Nucala has got off to a fair start in the market, bringing in £213m

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is a creative agency specialising in healthcare communication and understanding people's personality types....

Latest intelligence

Why pharma content marketing campaigns should be agile
Agile pharma content marketing is simply about responding to customer needs, rather than your own whims....
Grabbing your audience*
Highlighting one of our recent pieces of work - a powerful disease awareness film created in partnership with Watchable Films...
Defining Market Access and the Key to Success
Kevin Lennon, Head of Operations & Market Access at OUTiCO, shares his definition of market access and the key to success....

Infographics